Updated Oct. 22, 2013 at 4:40 p.m.

Premium Lock OxyBio shares close up 30% after trifecta: Acquires pharma firm, hires CEO, adds potential $600M drug

Published: 2013-10-22 10:45:00
Updated: 2013-10-22 16:40:17

John Kelley to lead combined company John Kelley to lead combined company. Image 1 of 2 · Next Image…

Wall Street likes this deal. Morrisville-based OxyBio says it is buying privately held Phyxius Pharma for some $4.8 million in stock and is naming the co-founder and CEO of that company as its chief executive officer. It's also acquiring the rights to a drug that could be worth $600 million a year....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2014 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Dr. Mike Walden
Tech economy
Frank Vinluan
Life science
Vivek Wadhwa
Commentary
Scroll